What is the pregnancy category for Enalapril Maleate?

Enalapril Maleate is classified as a pregnancy category D medication. This classification indicates that there is evidence of risk to the fetus based on human data, but the potential benefits may warrant its use in pregnant women despite the risks. Enalapril, an ACE inhibitor, can cause potential harm to the developing fetus, particularly during the second and third trimesters, where it has been associated with significant fetal effects including renal dysfunction and oligohydramnios.

In contrast, other categories such as A indicate that studies in pregnant women have not demonstrated a risk to the fetus in the first trimester, while category B suggests that animal studies have shown no risk but there are no adequate studies in pregnant women. Category C implies that animal studies have shown adverse effects and there are no adequate studies in humans. Since Enalapril is associated with clear risks during pregnancy, it does not fit within these categories, solidifying its classification as category D.